BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20090315)

  • 21. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.
    Briese S; Wiesner S; Will JC; Lembcke A; Opgen-Rhein B; Nissel R; Wernecke KD; Andreae J; Haffner D; Querfeld U
    Nephrol Dial Transplant; 2006 Jul; 21(7):1906-14. PubMed ID: 16554325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Options in dialysis therapy: significance of cardiovascular findings.
    Wizemann V; Timio M; Alpert MA; Kramer W
    Kidney Int Suppl; 1993 Feb; 40():S85-91. PubMed ID: 8445844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms.
    Cozzolino M; Biondi ML; Galassi A; Cusi D; Brancaccio D; Gallieni M
    Blood Purif; 2010; 29(4):347-51. PubMed ID: 20357434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular calcification and ESRD: a hard target.
    Bhan I; Thadhani R
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S102-5. PubMed ID: 19995990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.
    Papagianni A; Dovas S; Bantis C; Belechri AM; Kalovoulos M; Dimitriadis C; Efstratiadis G; Alexopoulos E; Memmos D
    Am J Nephrol; 2008; 28(2):265-74. PubMed ID: 17989499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vascular calcification and arteriosclerosis in chronic kidney disease patients].
    Rodríguez Portillo JM
    Med Clin (Barc); 2009 May; 132 Suppl 1():43-7. PubMed ID: 19460480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular factors influencing survival in dialysis patients.
    Alpert MA
    Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL; Swan VJ; Jamal SA
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular calcification in dialysis patients: pathogenesis and consequences.
    Reslerova M; Moe SM
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
    Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
    Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic kidney disease and atherosclerosis].
    Koike M; Nitta K
    Nihon Rinsho; 2011 Jan; 69(1):144-50. PubMed ID: 21226275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J
    Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitral annular calcification is associated with reduced left ventricular function and inflammation in patients with chronic kidney disease.
    Rao AK; Djamali A; Korcarz CE; Aeschlimann SE; Wolff MR; Stein JH
    J Am Soc Echocardiogr; 2008 Jun; 21(6):747-50. PubMed ID: 18187299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.
    Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D
    J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Abnormalities of lipid metabolism in chronic dialysis patients].
    Fujioka T; Saito E; Yasugi T; Shimizu T
    Nihon Rinsho; 1992 Jan; 50 Suppl():527-34. PubMed ID: 1578734
    [No Abstract]   [Full Text] [Related]  

  • 40. [A risk factors for stroke in the patients with chronic kidney disease].
    Kes P; Basić-Kes V; Basić-Jukić N; Jurić I
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():67-77. PubMed ID: 23120820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.